David Ripstein - 18 Mar 2026 Form 3 Insider Report for CERAGON NETWORKS LTD (CRNT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 13:41:44 UTC
Next SEC filing
26 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
David Ripstein by: Oppenheimer Israel, as Attorney-in-fact

Key filing fact

David Ripstein filed Form 3 for CERAGON NETWORKS LTD (CRNT) on 18 Mar 2026.

Key facts

  • This page summarizes David Ripstein's Form 3 filing for CERAGON NETWORKS LTD (CRNT).
  • 0 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 13:41.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001971502 Primary reporting owner

Ripstein David

Relationship
Director
Address
7 MIZAN ST., TEL AVIV
Signature
David Ripstein by: Oppenheimer Israel, as Attorney-in-fact
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRNT holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,010
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,397
Exercise price
$3.70
Footnotes
F2
CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,666
Exercise price
$2.09
Footnotes
F2
CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,666
Exercise price
$1.99
Footnotes
F2
CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
26,790
Exercise price
$3.08
Footnotes
F2
CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
14,850
Exercise price
$2.45
Footnotes
F2
CRNT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
33,700
Exercise price
$2.45
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were issued upon vesting of previously granted RSU's

Footnote F2

The Stock Options are Fully vested and immediately exercisable

SEC remarks

This Form 3 is being filed to report the Reporting Person beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .